Article
Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children.
AIDS research and human retroviruses - 20 Dec 1998
Principi N, Marchisio P, Esposito S, Rossi P, Gattinara G C, Galli L, Gabiano C, Zuccotti G V, Orlandi P
Abstract excerpt
Type and prevalence of zidovudine (ZDV) resistance mutations in HIV-1-infected children in clinically stable condition and on ZDV monotherapy were analyzed to evaluate the effect of switching to didanosine (ddI) monotherapy or to ZDV plus ddI on the pattern of mutations and on the clinical outcom...
Topics
- Anti-HIV Agents
- Base Sequence
- Child
- Codon
- DNA Primers
- Didanosine
- Drug Therapy, Combination
- Genotype
- HIV Infections
- HIV-1
- Humans
- Mutation
- Reverse Transcriptase Inhibitors
- Zidovudine